Oct 14th 2026

Cannabis for Chronic Pain: What the Evidence Actually Shows

Cannabis for Chronic Pain: What the Evidence Actually Shows

Cannabis for chronic pain may reduce pain a little for some adults, but the research does not support a simple yes-or-no answer. Results vary by the type of pain, product, dose, route, study length, and outcome measured. Much of the stronger research concerns neuropathic pain, which is pain related to damaged or irritated nerves. The CDC notes that evidence remains limited for most other kinds of pain.

That distinction matters if pain has become part of daily life. A product may change sleep, comfort, or the experience of pain without removing its cause. It may also produce side effects or interact with other treatment. The honest starting point for any claim about cannabis for chronic pain is a question: what was tested, in whom, for how long, and against what comparison?

What Does the Federal Review Say About Cannabis for Chronic Pain?

The widest view comes from the 2025 update of the federally commissioned living systematic review. A “living” review is updated as new research becomes available. Its evidence base included 29 randomized controlled trials involving 2,579 participants, plus 15 observational studies. Most of the studies were short term, lasting from four weeks to under six months.

The conclusions were narrower than many product claims:

• An oral spray containing roughly comparable amounts of THC and CBD probably produced a small reduction in pain, mainly in adults with neuropathic pain. Any improvement in daily function fell just short of what the reviewers count as a small effect.
• Oral synthetic or purified CBD alone probably did not improve pain or function.
• Evidence for whole-plant cannabis, topical CBD, low-THC products, comparisons with other pain treatments, and many longer-term outcomes remained insufficient.
• Dizziness, nausea, and sedation occurred more often with several THC-containing products.

That is not evidence of “no effect.” It is evidence of a modest average effect from particular standardized products under controlled conditions. A dispensary gummy, flower, vape, tincture, capsule, and topical are not interchangeable merely because all are labeled cannabis.

How Big Is the Benefit?

An updated systematic review published in late 2025 analyzed 25 short-term randomized trials with 2,303 participants, 64% of whom had neuropathic pain. Certain products with comparable THC and CBD, or with mostly THC, produced small average improvements in pain. Products that were mostly CBD may not have improved outcomes. The products associated with benefit also increased common adverse effects such as dizziness, sedation, and nausea.

Averages can hide individual variation. Some participants respond, others do not, and trial results cannot predict one person’s experience. They also should not be stretched beyond the patients, formulations, and time periods actually studied.

This is why cannabis for chronic pain is better discussed as a monitored trial of care than as a guaranteed solution. A pain score is one measure. Changes in sleep, mobility, daily tasks, or reliance on rescue medication are worth tracking too.

What Did the Large Back-Pain Trial Find?

A 2025 phase 3 trial studied VER-01, a standardized full-spectrum cannabis extract, in 820 adults with chronic low-back pain. The multicenter study was randomized and placebo-controlled, which makes it stronger than an uncontrolled patient survey or testimonial.

At week 15, 54.1% of participants receiving VER-01 achieved at least a 30% reduction in pain, compared with 39.5% receiving placebo. At least a 50% reduction was reported by 32.2% and 22.8%, respectively. The trial also reported better sleep, but adverse events, including dizziness, fatigue, and nausea, were more common with the extract.

This trial is encouraging, but it does not show that any retail cannabis product treats back pain. It tested one standardized oral investigational extract in a defined population. It is one piece of the evidence on cannabis for chronic pain, and it does not extend to other products or pain diagnoses. Our article on cannabis for back pain covers the trial in more detail.

Does CBD Alone Help Chronic Pain?

Current controlled evidence does not justify treating CBD as a proven general pain reliever. The federal review found that oral CBD alone probably did not improve pain or function, and the updated 2025 review similarly concluded that mostly-CBD products may not improve outcomes. Our guide to CBD vs. THC explains how the two differ.

That finding does not mean nobody reports benefit from CBD. It means the controlled trials have not established a dependable effect for chronic pain. Product quality and drug interactions add uncertainty. CBD can affect liver enzymes involved in processing medications, so patients taking prescriptions should discuss cannabis and drug interactions with a clinician or pharmacist.

What Are the Main Risks of Cannabis for Chronic Pain?

Possible benefits should be considered alongside impairment and adverse effects. THC can affect attention, memory, decision-making, coordination, and reaction time, so a person should not drive or operate machinery while impaired. Common trial-related effects from THC-containing products include dizziness, sleepiness, nausea, fatigue, and dry mouth.

The American College of Physicians advises clinicians to explain benefits and harms. It says the balance may be unfavorable for adolescents and young adults, people with current or past substance-use disorders, people with serious mental illness, and frail patients or those at risk of falling. It advises against cannabis during pregnancy, breastfeeding, or attempts to conceive, and against inhaled cannabis for chronic noncancer pain.

Do not stop opioids, antidepressants, seizure medicines, blood thinners, sleep medicines, or any prescribed treatment because you plan to try cannabis. Medication changes should be made with the prescribing clinician. A state medical card also does not make cannabis risk-free or appropriate for every patient.

Does Chronic Pain Qualify for a Medical Cannabis Card?

It depends on state law. Some programs name chronic, severe, or intractable pain directly. Others require a particular diagnosis, a minimum symptom duration, unsuccessful prior treatment, or a clinician’s finding that the condition is debilitating. CCOA’s state pages show how much the wording and pathways differ in Pennsylvania, California, Arkansas, Arizona, and Connecticut.

Certification is not automatic. A licensed clinician must review the condition and the rules that apply where the patient lives. Our guide to whether chronic pain qualifies for a card walks through eligibility, the CCOA locations page lists state-specific information, and the online medical cannabis evaluation page explains how to begin.

What Should You Prepare for an Evaluation?

A useful evaluation begins with more than the sentence “I have pain.” Bring information that helps a clinician understand the pattern, impact, and current treatment plan:

• The diagnosis, when available, and how long symptoms have persisted.
• Where the pain occurs and whether it feels burning, shooting, aching, or otherwise.
• How pain affects sleep, movement, work, caregiving, mood, or everyday tasks.
• Current medications, supplements, cannabis or CBD use, and known reactions.
• Treatments already tried and what helped, failed, or caused side effects.
• Relevant records, imaging reports, or a current medication list when available.

The purpose is not to “say the right thing.” It is to support an accurate, state-compliant clinical decision and a more careful discussion of risks, expectations, and alternatives. Readers can review CCOA’s patient portal and contact the clinic with practical questions.

Questions to Ask Before Trying Cannabis for Chronic Pain

Before trying cannabis for chronic pain, ask which outcome would count as meaningful improvement. Less pain may matter, but so might better sleep, easier walking, fewer disrupted activities, or improved ability to participate in physical therapy. Decide how those outcomes will be tracked and when the plan will be reassessed.

Also ask about the product type, THC exposure, impairment, medication interactions, fall risk, mental-health history, workplace testing, and driving. Research on cannabis for chronic pain does not transfer cleanly from one formulation to another, so “Which product was studied?” is often more useful than “Does cannabis work?” Our list of questions to ask a medical cannabis physician can help you prepare.

Cannabis for Chronic Pain: Frequently Asked Questions

Is cannabis proven to treat all chronic pain?

No. Evidence on cannabis for chronic pain is strongest for small, short-term effects from certain THC-containing products in studies dominated by neuropathic pain. Evidence for many other pain conditions, retail formulations, topical products, and long-term use remains limited or insufficient.

Is THC or CBD better for chronic pain?

Current reviews find more evidence of small pain reductions with some THC-containing products than with CBD alone. Those products also produce more dizziness, sedation, nausea, and impairment, so “more evidence” does not mean “better for everyone.”

Can cannabis replace my current pain medication?

Not without a clinician-directed plan. The evidence does not support independently stopping a prescribed treatment, and combining cannabis with other sedating substances may increase impairment. Discuss goals, interactions, and any taper with the prescribing professional.

How long has cannabis for chronic pain been studied?

Most controlled trials in the major reviews were short term, generally one to six months. Long-term benefits and harms remain a major evidence gap.

Does a medical cannabis card guarantee pain relief?

No. Certification concerns legal eligibility under a state program. It does not guarantee that cannabis will be effective, tolerated, or appropriate. Individual response and state requirements vary.

What is the next step if I want to explore eligibility?

Review your state’s rules and arrange an evaluation with a clinician authorized under that program. Compassionate Clinics of America offers state information and an option to begin an online evaluation, but eligibility and certification depend on the individual assessment.

The Practical Bottom Line

The strongest current evidence on cannabis for chronic pain supports a careful middle position. Certain standardized, THC-containing products may provide small short-term benefits for some adults, while CBD alone has not shown dependable pain relief in controlled trials. Side effects are common enough to matter, and research still leaves major questions about long-term use, product differences, and many specific pain conditions.

If persistent pain may qualify under your state’s program, check your state and begin an evaluation. That visit does not guarantee certification or relief. It is an individualized review of eligibility, current treatment, possible risks, and reasonable expectations.

This article is for educational purposes only and does not provide medical or legal advice. Cannabis laws and program rules vary by state and change over time. Do not start, stop, or change prescribed treatment without consulting the appropriate licensed clinician. Cannabis can cause impairment and other adverse effects and is not appropriate for every person.